beta-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial (2018)
- Authors:
- USP affiliated authors: FARIAS, ALBERTO QUEIROZ - FM ; CARRILHO, FLAIR JOSÉ - FM ; ALBUQUERQUE, LUIZ AUGUSTO CARNEIRO D - FM
- Unidade: FM
- DOI: 10.1097/MEG.0000000000001128
- Subjects: CIRROSE HEPÁTICA; CARDIOPATIAS; HIPERTENSÃO PORTAL; RATOS; ESTUDOS RANDOMIZADOS; BETA-BLOQUEADORES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2018
- Source:
- Título do periódico: European journal of gastroenterology & hepatology
- ISSN: 0954-691X
- Volume/Número/Paginação/Ano: v. 30, n. 8, p. 930-937, 2018
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SILVESTRE, Odilson M. et al. beta-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial. European journal of gastroenterology & hepatology, v. 30, n. 8, p. 930-937, 2018Tradução . . Disponível em: https://doi.org/10.1097/MEG.0000000000001128. Acesso em: 30 abr. 2024. -
APA
Silvestre, O. M., Farias, A. Q., Carrilho, F. J., & Albuquerque, L. A. C. (2018). beta-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial. European journal of gastroenterology & hepatology, 30( 8), 930-937. doi:10.1097/MEG.0000000000001128 -
NLM
Silvestre OM, Farias AQ, Carrilho FJ, Albuquerque LAC. beta-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial [Internet]. European journal of gastroenterology & hepatology. 2018 ; 30( 8): 930-937.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1097/MEG.0000000000001128 -
Vancouver
Silvestre OM, Farias AQ, Carrilho FJ, Albuquerque LAC. beta-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial [Internet]. European journal of gastroenterology & hepatology. 2018 ; 30( 8): 930-937.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1097/MEG.0000000000001128 - Interações Cárdio-Hepáticas – da Hipótese dos Humores ao Transplante de Órgãos
- Transcatheter aortic valve implantation as rescue therapy for liver transplant candidates with aortic valve stenosis [Carta]
- Serum B-type natriuretic peptide in the initial workup of patients with new onset ascites: A diagnostic accuracy study
- Impact of the severity of end-stage liver disease in cardiac structure and function
- Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: effect on conventional coagulation tests and thrombomodulin-modified thrombin generation
- Doenças hepáticas causadas por bactérias, parasitas e/ou fungos
- Renal insufficience leads to increased mortality in post-liver transplantation
- Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage
- m-RECIST at 1 month and child A are survival predictors after percutaneous ethanol injection of hepatocellular carcinoma
- Liver Elastography in Acute Cellular Rejection After Liver Transplantation
Informações sobre o DOI: 10.1097/MEG.0000000000001128 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
